Objective: Our study aims at determining safety and efficacy of oral micronized progesterone in preventing preterm labor. Method: Study conducted at Sahiwal Teaching Hospital from June 2018-July 2019 including 180 participants with preterm labor. Oral micronized progesterone give 200 microgram twice daily till preterm labor settled. Results: 12.5% were =20 years. 31% were 20-25 years. 35% were from 25-30 years. While 36(22%) were =35 years. Primigravida were 27% and multigravida 73%. In 76% cases preterm labor settled and 24% had labor = 37 weeks. Latency period = 24 hours in 15% ,2-6 days in 18%, 1-3 weeks in 24%, 4-8 weeks in 32%, 9-12 weeks in 7%, = 12 weeks in 5% respectively. 78% had vaginal delivery, C-Sec in 22% of patients. Gestational age at delivery =28 weeks in 7%, =32 weeks in 20%, =36 weeks in 25% and =37 weeks in 48% respectively. Birth weight, = 3.0 kg in 25%, 2.0-2.5 kg in 50%, = 2.0 kg 18%, = 1.5 kg 7%. NICU admission 25%. RDS seen in (22%), Sepsis (10%), IVH (3%), NEC (1%). neonatal deaths were 12. Conclusion: Oral micronized progesterone is found to be safe, effective and well tolerated therapy for prevention and treatment of preterm birth.